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The comparative cytotoxicity of riddelliine in primary mouse, rat and chick 
hepatocytes 
Abstract 
Dehydropyrrolizidine alkaloid (DHPA) producing plants commonly poison livestock, wildlife and humans. 
Poisoning occurs when DHPAs are ingested as feed or food, or when they contaminate medicinal or 
herbal products. Direct toxicologic comparison of individual DHPAs is essential to estimate their actual 
health risks. This has been problematic due to varying models and difficulties in DHPA isolation or 
synthesis. In contrast, the macrocyclic DHPA riddelliine is readily isolated and it has been used as a 
benchmark to characterize different models of toxicity and carcinogenicity. Following earlier work with 
immortalized cell lines, the objective of this study was to characterize the effect of riddelliine on primary 
mouse, rat and chick hepatocyte cultures with the aim of developing a suitable, sensitive model for 
assessing DHPA-related cytotoxicity. After establishing viable cultures, the hepatocytes were exposed for 
24 hours to riddelliine (from 0.1µM to 1.2mM) and cytotoxicity (CT50) was estimated using a 
mitochondrial function assay (MTT). Despite a biphasic response, possibly attributable to a sub-
population of resistant chick hepatocytes, chick hepatocyte cultures were highly sensitive (CT50 0.9 µM) 
to riddelliine cytotoxicity relative to rat (CT50 289 µM) and mouse (CT50 627 µM) hepatocytes. Chick, 
mouse and rat hepatocyte cytochrome P450 3A4 activities did not correlate with riddelliine-induced 
cytotoxicity. With further development to utilize the highly sensitive primary chick hepatocytes, this model 
may be useful to directly compare panels of DHPAs, including rare or difficult to isolate alkaloids. 
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Introduction: Dehydropyrrolizidine alkaloid (DHPA) producing plants are well 
documented as causes of intoxication of livestock, wildlife and humans (Edgar et 
al. 2011; Stegelmeier et al. 1999; Beier 1990; and Mattocks 1986).  Reported 
clinical effects and histopathologic lesions include hepatic degeneration and 
necrosis with less frequent vascular and veno-occlusive disease, portal 
hypertension, pulmonary hypertension or nephrosis.  Most exposures are relatively 
acute or sudden since DHPA-producing plants, or parts there from, are ingested 
over several hours or days.  This is often due to the invasive nature of many DHPA-
producing plants allowing them to infest pastures, ranges, crops and contaminate 
feeds and foods. The DHPA-producing plants can also be included or inadvertently 
contaminate herbal products.  However, poisoning is often inconsistent due to 
toxicity differences associated with DHPA structure (physical and chemical 
properties); environmental or geographic variations that alter plant toxins and 
concentrations; or species susceptibility and variation in response to poisoning 
(Molyneux et al. 2011).  These inconsistencies often make it difficult to obtain a 
definitive poisoning diagnosis and, more importantly, when associated with 
different models of toxicity make it difficult to compare individual DHPA toxicity 
and predict risk.  For example, Cynoglossum officinale (houndstongue) was 
originally reported not to poison aged ponies (Knight et al. 1984). However, 
additional studies found young animals are highly susceptible to houndstongue 
poisoning (Stegelmeier et al. 1996).  Houndstongue major alkaloids include 
heliosupine, 3'-acetylheliosupine, echinatine and 7-angeloylheliotridine and the 
concentrations of these alkaloids varies in different plant phenological stages and 
different plant parts (El-Shazly et al. 1996).  This results in plant toxicity variation 
from none to highly toxic and fatal.  This impairs meaningful risk assessment 
suggesting that all exposures have to be considered potentially dangerous (El-
Shazly et al. 1996; Stegelmeier et al. 1996).  Similar to houndstongue, many other 
DHPA-producing plants have variations in alkaloids and concentrations resulting 
in a poor or unreliable understanding of the toxic potential of their individual and 
combined alkaloids.   
In addition to these relatively acute exposures and their toxic sequelae, there 
is increasing worldwide concern about the potential health risks due to cumulative, 
intermittent or long-term, low-dose DHPA exposures.  Such risks include an 
increased incidence of cancers and other chronic diseases (Brown et al. 2015; Edgar 
et al. 2015).   Current indications suggest that bioactivation and metabolism of all 
DHPAs lead to the same toxic and potentially carcinogenic entities (Edgar et al. 
2011).  Consequently many existing regulations or recommendations regarding 
human exposure to DHPAs do not differentiate between the individual alkaloids.  
However, variation in alkaloid toxicity suggest this may not be accurate.  Even 
though both clinical and mechanistic studies suggest many chronic DHPA 
exposures have carcinogenic potential, only two, lasiocarpine and riddelliine, have 
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been listed as Class 2B carcinogens (IARC 2017; Chan 1993).  More work is 
needed to better characterize individual DHPA toxicity and to determine if all 
DHPAs have similar carcinogenicity.   Consequently, research efforts have been 
expanded to include development of in vivo and in vitro models to directly compare 
the relative toxicity and carcinogenic potentials of purified DHPAs of both acute 
and chronic exposures (Brown et al. 2015; Brown et al. 2016; Field et al. 2015).  
These models have identified several DHPAs that are more toxic and probably 
more carcinogenic than riddelliine.  However, a preliminary, highly sensitive 
screening of DHPAs is needed to better compare DHPAs that are available only in 
limited amounts.   Such direct side by side comparison will enable rational selection 
of DHPAs for in vivo studies and to better predict the impact and risk of less toxic, 
rare DHPAs.   
Cell culture models have been used to study both DHPA-induced toxicity 
and metabolism (Mattocks 1986).  Directed by observations that chicks are highly 
sensitive to DHPA-induced toxicity (Brown et al. 2016), an in vitro chicken 
hepatocarcinoma (CLR-2118) model was developed and used to define a riddelliine 
CT50 (the concentration at which cell viability is 50% of the maximum response) 
of 192 µM compared to more than 100 mM for human HepG2 cells (Field et al. 
2015).   However, it has been suggested that primary, competent hepatocyte 
cultures (cells that are not dependent on co-culturing with other cells or microsome 
preparations to activate DHPAs) might be better models to study toxicity (Reindel 
and Roth 1991).   
DHPA are bioactivated by liver mixed function oxidases.  Of these, the 
cytochrome P450 (CYP) sub-families CYP3A and CYP2B have been reported to 
be the major hepatic CYPs that oxidize many DHPAs (Fu et al. 2004; Mattocks 
1986).  Recent primary human hepatocyte cultures identified a battery of CYP1A1, 
CYP1A2, CYP2A6, CYP3A4, CYP3A5, CYP2B6, CYP2C9, CYP2C19, CYP2D6, 
and CYP2E1 that could potentially metabolize DHPAs (Raun et al. 2014).  Similar 
large batteries have also been identified in animals (Gordon et al. 2000).  However, 
such lists are misleading as they indicate CYPs may metabolize DHPAs, but their 
relative importance has not been confirmed.  Certainly CYP in vivo function is 
limited by alkaloid affinity and subsequent DHPA specificity and rates of 
metabolism.  Consequently, most DHPAs are principally metabolized in vivo by 
only one or two CYPs (Ruan et al. 2014; Mattocks 1986).  CYP3A4 has been 
identified as playing a major role in hepatic DHPA activation in man, mice, rats 
and chickens (Fashe et al. 2015; Haun et al. 1998a; Haun et al. 1998b).  There are 
both species and individual variation in CYP activity and recently increased 
CYP3A4 activity has been linked to increased DHPA toxicity.  A woman developed 
severe liver injury that was associated with increased CYP3A4 activation of 
echimidine from contaminated pollen while her similarly exposed husband with 
more normal CYP activities was unaffected (Rollason et al. 2016).  As such 
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differences in CYP activities may also play a role in carcinogenicity of DHPAs, it 
would be beneficial to better correlate CYP expression relative to individual DHPA 
toxicity and later carcinogenicity. 
The objectives of this present work were to: 1) determine the relative 
cytotoxicity of riddelliine in rat, mouse and chicken primary hepatocytes as 
measured by cell viability (MTT), 2) determine and compare the activity of 
hepatocyte cytochrome P450 3A4 (CYP3A4) in these species to determine if 
activity is related to cytotoxicity, and, 3) compare the in vitro cytotoxicity with 
available animal and clinical studies as described in the literature. 
 
Materials and Methods: Riddelliine was accessed from the collection of 
pyrrolizidine alkaloids held by the Poisonous Plant Research Laboratory.  It was 
initially isolated from Senecio riddellii; reduced to the free base; and verified 
chromatographically to be greater than 99% pure (Colegate et al. 2017; Brown et 
al. 2015).  A stock solution and subsequent dilutions were made using absolute 
ethanol and checked for lack of hydrolytic ring-opening (Colegate et al. 2017).  
Hepatocytes were isolated from rat, mice and chick livers using modifications of 
techniques previously described by Ji et al. (2010).  Briefly the entire rat (12-week-
old, male, Sprague Dawley), mouse (12-week-old, male, BALB/c) and chick (3 to 
6 -week-old, male, white California leghorn) livers were perfused and excised from 
euthanized animals (CO2 narcosis followed by exsanguination following protocols 
approved by the Utah State University Institutional Animal Care and Use 
Committee (Protocols #2474 and 2643)).  These ages were chosen as young 
weaning age animals are more sensitive to DHPA toxicity (Stegelmeier et al.1999; 
Mattocks 1986).  Within minutes of euthanasia, the livers were perfused in situ via 
catheterization of the portal vein using perfusion HEPES buffer (Gibco 
ThermoFisher Scientific, Logan, UT) -  pH 7.6 at 37°C at a flow rate of 10 mL/min 
until the liver blanched and then with perfusion buffer plus 0.05% collagenase type 
II (ThermoFisher Scientific, Logan, UT)  at 25 mL/min for 6 min.  The livers were 
placed in a sterile beaker with 20 mL William’s complete media (ThermoFisher 
Scientific, Logan, UT) and gently broken into small 1 mm fragments using a sterile 
spatula.  The mixture was strained through a 100 µm filter into a sterile conical 
tube.  The cells within the filtrate were pelleted by spinning at 50 x g for 3 min at 
4°C.  The supernatant was removed and the pellet dispersed into 3°C William’s 
complete media (20 mL).  This washing was repeated 2 times. Finally the cell pellet 
was re-suspended in warm (37°C) William’s complete medium (20 mL) and the 
cells were counted using a hemocytometer and examined microscopically 
identifying them as viable hepatocytes using trypan blue exclusion.  The 
hepatocytes were then seeded into 96-well growth plates at 1.5X105 cells/well 
(resulting in about 90% confluence).  The cells were allowed to adhere by culturing 
(37°C with 5% CO2) for 12 hours with a medium change at 4 hours.  After 12 hours 
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the medium was changed to include riddelliine.  All cells were then incubated for 
24 hours with 9, 18, 38, 75, 150, 300, 600, and 1200 µM riddelliine while the chick 
cells were also incubated with 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4, 6 and 8 µM riddelliine 
in William’s complete media.   
The hepatocytes were evaluated microscopically to evaluate cellular 
integrity and then cytotoxicity was quantitated using a mitochondrial function assay 
(colorimetric measurement of formation of formazan from 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide, MTT) following the manufacturer’s 
suggested protocol (CellTiter 96R non-radioactive Cell Proliferation Assay, 
Promega, Madison WI- MTT).  All assays were done in triplicate (hepatocytes 
harvested from 3 different animals) with 2 replicates or plates for each animal.  The 
cytotoxicity 50 (CT50) was estimated by determining the riddelliine concentration 
that produces ½ the maximal response (total SDS-induced cellular lysis following 
the CellTiter suggested protocol).   
To compare the hepatocellular cytochrome P450 3A4 (CYP3A4) activities, 
microsome preparations from the livers of 6 mice, rats and chicks were separately 
processed as described by Klein et al. (2000).  The CYP3A4 activities were then 
measured using a luciferin-based assay also following the manufacturer’s 
suggested protocol (P450-GloTM CYP3A4 Assay with Luciferin-IPA, Promega, 
Madison WI) using a Molecular Devices Flexstation 2 (Sunnyvale, CA USA) 
measuring absorbance at 570 nm.  The MTT means, CT50 and CYP3A4 means were 
compared using analysis of variance to identify significant difference (P<0.05) and 
the means were separated using Duncan’s procedure (Proc GLM SAS 9.3 Cary 
NC). 
 
Results: The hepatocyte cultures from the three species were morphologically 
identified as predominately hepatocytes and nearly all cells had adhered in the wells 
with about 90% confluence.  After the washes and media changes the tested cells 
were composed of approximately 95% hepatocytes with fewer numbers of 
mononuclear cells, fibroblasts and rare erythrocytes (Figure 1A).  When incubated 
with riddelliine the cells became swollen and often detached from the surface of the 
well to float in the medium (Figure 1B).  Severely damaged cells had nuclear 
pyknosis, karyorrhexis and cytoplasmic blebs, the latter leading to rupture and 
consequent fragments of cellular debris in the medium (Figure 1C).  The 
morphologic cellular degeneration and necrosis was reflected metabolically with 
decreased MTT metabolism (Figure 2 and Table 1).   
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Figure 1: Incubating primary chicken hepatocytes that were incubated for 24 hours with 0(A), 5(B), 
and 600 µM riddelliine (C). These photographs were created in the plates with an inverted 
microscope using phase contrast resulting in limited resolution. The chick hepatocytes are 
morphologically different than other species.  Notice the mostly normal chick hepatocytes (A) have 
smooth cell margins and though they are attached to the well bottom they do not spread out on the 
plate like mouse or rat hepatocytes (A).  Degenerative hepatocytes incubated with riddelliine have 
rough cell margins (B and C), they often detach and rupture resulting in debris and cellular fragments 
floating in the media.  Notice 30-40% of the cells appear more normal (C).  This is reflected in the 
MTT results as some cells appear to be resistant to riddelliine cytotoxicity.   
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Table 1:  Comparison of MTT metabolism (expressed as percent of control) in primary hepatocytes 
from chicks, rats and mice incubated with increasing riddelliine concentrations (µM).  The means 
were produced from three replicates (plates) with each riddelliine concentration ran in duplicate.  
The significantly different means (P<0.05) within the species for different riddelliine concentrations 
are indicated with capital superscripts.  Significantly different means (P<0.05) between species at 
the same riddelliine concentration are indicated with small letter superscripts.  
 
Riddelliine 
Concentration µM 
Chick Hepatocytes Rat Hepatocytes Mouse 
Hepatocytes 
0.1 99.8±4.8A   
0.2 99.0±5.5A   
0.3 94.7±2.6A   
0.4 61.6±2.4B   
0.5 56.6±3.3BC   
1.0 52.3±2.8CDE   
2.0 54.3±4.2BC   
3.0 49.6±3.5CDE   
4.0 52.0±2.3CDE   
6.0 47.1±1.7DEF   
8.0 52.3±3.9CDE   
9.0 51.1±13.0CDE  a 84.3±11.0A    b 98.7±5.4AB    c 
10 51.8±4.3CDE      
18 62.2±13.6B    a 67.2±14.1B    a 93.6±7.8ABC   b 
38 43.5±8.5EF   a 58.3±10.3B    b 70.0±13.2BC   b 
75 52.8±12.2CDE  a 69.7±16.8AB   ab 78.3±13.9ABC   b 
150 47.3±11.3CDEF  a 40.9±20.6C    a 84.7±14.3ABC   b 
300 46.1±11.3 DEF  a 43.1±11.0C    b 107±10.2AB   b 
600 39.5±8.1FG   a 3.4±1.4D    b 55.5±1.7 C    c 
1200 34.3±4.0G   a 11.8±3.5D   b 23.7±15.7D   ab 
 
The mean calculated CT50s for the rat and mouse hepatocytes were 289±101 µM 
and 627±88 µM riddelliine, respectively (Table 2).  In vivo studies in both mouse 
and rat suggest that morphological changes were evident at riddelliine doses 
between 600 to 900 µM which are similar to these CT50’s.  By contrast, chick 
hepatocytes were much more sensitive with an estimated CT50 of 0.9±0.04 µM, 
statistically different to the rat and mouse hepatocyte cultures (Table 2). 
Morphologic changes in chick hepatocytes were evident at riddelliine doses 
between 6 to 10 µM.  The mouse and rat MTT responses were variable with 
relatively high standard deviations such that only the relatively high concentrations 
of 600 and 1200 µM were significantly different than the lower exposures.  In 
contrast, the consistent response (low variability) of chick hepatocytes between 0.1 
and 1 M and again between 1 and 10 µM demonstrate a significant initial 
reduction of about 40% in MTT metabolism (cytotoxicity) followed by similar 
responses between 40 and 50% suggesting a short plateau in which additional cells 
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were not damaged (Figure 2).  At higher concentrations between 18 and 1200 µM 
the MTT response had increased variability with gradual decreases to a maximal 
response of about 30% of control.   This high concentration response with increased 
variability was similar to that seen in both rat and mouse hepatocytes exposed to 
similar riddelliine concentrations (Figure 2, Table 1).  The rat MTT response was 
lower nearly to zero at high riddelliine concentrations.  Chick hepatocyte MTT 
metabolism at 600 and 1200 µM concentrations was significantly less than that seen 
at the lower exposures.  This bi-phasic response of the chick hepatocyte culture was 
clearly different to the response of the mouse and rat hepatocyte cultures (Figure 2, 
Table 2).   
 
 
Figure 2: Cytotoxicity of primary chicken, mouse and rat hepatocytes exposed to riddelliine.  
Cytotoxicity was estimated using MTT (a mitochondrial function assay).  Notice the biphasic 
response of chicken hepatocytes as about half the MTT activity lost between 0.1 and 0.6 µM.  The 
response then plateaus between 1 and 10 µM and gradually decreases at higher doses between 18 
and 1200 µm. The rat and mouse response was similar to chick hepatocytes with decreases in MTT 
starting at about 50 µM with most cytotoxicity occurring between 200 and 800 µM. 
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Table 2:  Cytochrome P450 3A4 activities and riddelliine-induced 50% cytotoxic doses (CT50) in 
rat, mouse and chick primary hepatocytes.  Data are presented as means ± standard deviation. 
Significantly different means between species are indicated by superscript letters.  
 
 Species CT50 µM Riddelliine CYP3A4 µM d Luciferin 
Chick 0.9±0.04 A 17.3±7.7 A 
Rat 289±101 B 252.5±87.0 B 
 
The mean microsomal CYP3A4 activities (µM D-luciferin produced in 30 
min) were similar for chicks (17.3±7.7) and mice (11.4±4.4), but significantly less 
(P = 0.001) than rats (252±87) (Table 1).   
 
Discussion:  The purpose for developing rapid and sensitive in vitro DHPA 
bioassays is to offer a direct, side by side comparison of alkaloid toxicity, especially 
those alkaloids that are rare, or difficult to isolate or synthesize. Benchmark 
alkaloids such as riddelliine allow meaningful risk estimation.  Ideally, the assays 
should be biologically relevant in terms of approximating natural exposures and 
they should allow extrapolation of in vitro observations to in vivo predictions for 
specific livestock species and especially humans. Ideal assays would also provide 
a useful preliminary screening bioassay for selecting specific alkaloids for more in-
depth studies of their genotoxic and/or carcinogenic potential.   
Animal toxicity studies with Senecio riddellii have shown that doses of 15 
mg “total pyrrolizidine alkaloid/kg bodyweight per day for 20 days are lethal to 
calves” (Johnson et al. 1985).   S. riddellii contains primarily riddelliine N-oxide 
with a small amount of free base; however, it has been shown that orally 
administered riddelliine N-oxide is as toxic as its free base riddelliine.  This is 
presumably due to reduction in the digestive tract prior to absorption (Molyneux et 
al. 1991).   Assuming complete reduction of the N-oxide and complete absorption 
of riddelliine from the digestive tract, both of which are unlikely, the daily body 
riddelliine concentration would be about 40 µM.  This crude estimate does not 
account for complicating factors such as absorption differences, portal circulation, 
first pass hepatic metabolism and potential accumulation in some tissues (Mattocks 
1986), but the implication is that suitable in vitro DHPA bioassays probably need 
to be sensitive in the low µM range.  This assumption is supported by toxicokinetic 
studies of riddelliine, in which serum riddelliine concentrations of 0.7 µM in rats 
and 1.4 µM in mice were measured following a single, oral gavage of 10 mg 
riddelliine/kg bodyweight (Williams et al. 2002).  In this primary cell culture study 
the CT50s were estimated to be 627 and 289 µM riddelliine for mouse and rat 
hepatocytes respectively (see Table 2).  This is similar to other rodent primary 
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hepatocyte DHPA studies (Ji et al. 2010; Williams and Mori 1980).  These 
cytotoxic concentrations are much higher than the observed (or conservatively 
estimated) in vivo concentrations following oral dosing with riddelliine.  As 
mentioned previously, the CT50 of riddelliine was estimated to be 192 uM in 
immortalized chick hepatocarcinoma CLR-2118 cells (Field et al. 2015), again 
higher than the target in vivo concentrations.  While this assay is adequate for 
relatively toxic alkaloids such as senecionine, seneciophylline, or lasiocarpine, it 
may lack the sensitivity needed to compare some rare or less toxic alkaloids.  By 
comparison, the chick primary hepatocyte culture, despite the biphasic nature of the 
response, defined cytotoxicity of riddelliine with a CT50 ~ 0.9 µM.  This estimate 
of cytotoxicity was mathematically obtained and replicated with standard deviation 
of 0.4 µM.  However, Figure 2 indicates this CT50 is on the central flat portion of 
the response curve where there is little difference in response with adjacent 
concentrations (0.8 to 10 µM).  While more work is needed to better understand 
this response, the conclusion that primary chick hepatocytes are more sensitive to 
riddelliine cytotoxicity appears valid.  With, or without further development to 
identify and address the reasons for the biphasic response, this additional sensitivity 
might enable the determination of physiologically relevant in vitro CT50s for a wide 
range of DHPAs.  For example, Field et al. (2015) defined a CT50 > 300 M for the 
retronecine monoester dehydropyrrolizidine alkaloids lycopsamine and 
intermedine, and 256 M for the macrocyclic diester monocrotaline.  This 
essentially ranks them as equally toxic, even though clinical exposures suggest they 
have different toxicities and associated clinical diseases (Mattocks 1986).  
Comparing their cytotoxicity against riddelliine in the chick primary hepatocyte 
culture may provide a more physiologically relevant assessment of their actual 
cytotoxic and clinical toxic potential.   
Riddelliine cytotoxicity increased between concentrations of 9 and 600 µM 
with a trending, gradual increase in cytotoxicity in rat hepatocytes.  In mouse 
hepatocytes there was little riddelliine-induced cytotoxicity at 9 and 18 µM while 
cytotoxicity increased with the maximum effect seen at 1600 µM.  Riddelliine 
cytotoxicity in both rat and mouse hepatocytes, especially at higher concentrations, 
are indicative of a variable dose-associated response of resistant, homogeneous cell 
populations (Figure 2, Table 1).  By contrast, the apparent biphasic response of the 
chick hepatocytes indicates a more complex response.  It may be that the outwardly 
homogenous population of cells is in fact comprised of two sub-populations, one 
more resistant to riddelliine than the other.  Similar cellular differences are often 
seen in histologic studies as some toxins affect only certain morphologic zones 
within the hepatic lobule (Allen et al. 2005).  Alternatively, it may be that the 
metabolic activation of riddelliine by the chick hepatocytes is different than that of 
the mouse and rat hepatocytes.  Activating metabolic enzymes in chick hepatocytes 
might become overwhelmed, seemingly causing no increase in toxicity with 
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increased riddelliine concentrations.  Similar impressions of reduced toxicity in the 
face of higher doses have also been postulated in studies using intra-ruminal 
infusion of riddelliine or its N-oxide in livestock (Molyneux et al. 1991).  It has 
also been suggested that the initial DHPA exposure may saturate or temporarily 
inhibit the synthesis of oxidative enzymes required for activation (Shull et al. 
1976).  Biphasic MTT responses have also been described when immortalized 
human fibroblast cultures were incubated with ciprofloxacin.  Concentrations 
between 50-75 mg/L produced dose responsive cytotoxicity while doses higher 
than 75 mg/L were not cytotoxic.  The authors suggested that higher doses 
upregulated intracellular glutathione, catalase, superoxide dismutase and 
glutathione peroxidase resulting in decreased oxidative damage (Hincal et al. 
2003).  Biphasic cytotoxic responses have also been attributed to toxins that alter 
apoptosis.  Lithium chloride alters apoptosis-regulating glycogen synthase kinase 
3ß and other caspases activities in human breast adenocarcinoma cells (MCF-7) 
thereby changing dose-related cytotoxicity (Suganthi et al. 2012).  It is not 
presently known if similar metabolic changes contribute to the DHPA-induced 
chick hepatocyte response.  The initial response seen in primary chick hepatocyte 
cultures might be used to develop a sensitive cytotoxicity assessment tool.  Future 
development and investigation may determine the mechanism of the biphasic 
response and allow the sensitive cells to be isolated or enhanced so that all respond 
uniformly, avoiding the biphasic response.   
The CT50s estimated for the rat hepatocytes (289 µM riddelliine) and mouse 
hepatocytes (627 µM) indicated that the rat hepatocytes were more susceptible to 
the cytotoxic effects of riddelliine. This is in agreement with the reported higher 
susceptibility of rats to riddelliine-induced carcinomas relative to mice (IARC 
2017; Chan 1993).   Both the initial dose-related response of the chick hepatocytes 
between 0.1 and 0.8 µM and the relatively stable plateau between 1 and 10 µM 
have minimal variation.  At increasing concentrations between 150 and 1200 µM 
there was increased cytotoxicity that was similar in both response and variability to 
mouse and rat hepatocytes.  At these concentrations there was no statistical 
difference in mean MTT metabolism between these species (Figure 2 and Table 1).  
However, at 1200 µM riddelliine the rat hepatocytes were nearly all necrotic and 
MTT metabolism was lower than, and significantly different to the rates for the 
mouse and chick hepatocytes.  Higher concentrations (data not shown) did not 
further damage any of the surviving cells.  At 1200 M, the metabolism of MTT 
by the chick and mouse hepatocytes was about 30% of control MTT metabolism 
suggesting that, for presently unknown reasons, a small number of hepatocytes are 
resistant to riddelliine cytotoxicity.    
The CYP3A4 assays (Table 2) are estimates as specificity has not been 
verified in all species; however, they are often useful for comparison.  These results 
suggest that the rat hepatocytes have significantly higher activities than mice or 
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chicks.  Since this is not reflected in the hepatocyte response to riddelliine, it also 
suggests that CYP3A4 activity is not a major factor in riddelliine toxicity in these 
species.  However, it may be an essential component of other DHPA toxicity.  The 
various CYP activities are toxin specific and it has been suggested that for some 
DHPAs other unidentified esterases may be more important in tipping the balance 
between toxicity and detoxification (Tang et al. 2007).  Nonetheless, CYP3A4 has 
been shown to be important in DHPA activation in many species (Fu et al. 2004).  
For example, lasiocarpine is primarily activated by CYP3A4 in human hepatocytes 
(Fashe et al. 2015) and the CYP3A family activates senecionine in sheep and 
hamsters (Huan et al. 1998a).  These suggest the possibility that these results are 
riddelliine-specific and that other DHPA cytotoxicity may be more dependent on 
CYP3A4 activation.  It is unknown whether CYP3A4 expression impacts the 
response of other species to riddelliine or whether upregulated expression of other 
specific CYPs affects species responses to other individual DHPAs.   
Although the CYPs that activate the different DHPAs in chickens have not 
been definitively identified, chicken CYP activity and adduct production has been 
documented and linked to DHPA toxicity in chickens (Fashe et al. 2015; Haun et 
al. 1998b).  Since the data reported in this present study indicate that CYP3A4 
activity is not correlated to in vitro cytotoxicity of the chick, rat and mouse primary 
hepatocytes, further investigations are required. These will include testing of a 
wider range of DHPAs to determine whether the primary chick hepatocytes are 
universally, or generally more sensitive than the rat and mouse hepatocyte cultures. 
There is also a need to assess the relative activities of various CYPs in the three cell 
lines to determine whether the increased cytotoxicity in the chick hepatocytes can 
be attributed to an increased activity of a specific CYP in the chick cells, relative 
to the rat and mouse cells.  
Toxin activation and detoxification, especially oxidative status, determines 
DHPA toxicity.  It has been suggested that DHPA-related disease occurs when 
pyrrole production overwhelms detoxification.  Many pyrroles are conjugated with 
glutathione and excreted in the bile. Increasing cellular oxidative stress can 
overwhelm this detoxification mechanism.   DHPA cytotoxicity increases lipid 
peroxidation and overwhelms glutathione peroxidase, glutathione S-transferase, 
and glutathione reductase.  Low doses of DHPAs often induce increases in catalase 
while all DHPA doses reduce superoxide dismutase activities.  These changes 
indicate oxidative stress and damage to cellular oxidative protection mechanisms 
(Ji et al. 2010).  Differences in the glutathione antioxidant system have also been 
associated with differences in DHPA susceptibility related to age and gender in 
mice (Liang et al. 2011a; Liang et al. 2011b).  Additionally antioxidants such as α-
tocopherol or quercetin can be protective against DHPA-induced damage (Ji et al. 
2014; Molteni et al. 2004).  The effect is also apparent clinically as animals under 
oxidative stress are more susceptible to DHPA-induced disease.  For example, 
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Amsinckia intermedia Lehmann or fiddleneck contains DHPAs but poisoning in 
livestock is rare.  In some areas there is little other forage and apparently resistant 
animals eat nothing but fiddleneck without obvious poisoning.  However, in cattle 
concurrently poisoned with Isocoma plurifora (burroweed) the combined oxidative 
stress with fiddleneck produces both muscular necrosis characteristic of burroweed 
poisoning and fiddleneck-induced liver disease (Panter et al. 2017).  Similar 
intermittent poisonings have been associated with Echium spp. and other DHPA-
containing plants (Betteridge et al. 2005; Culvenor et al. 1981).  
Despite the increased sensitivity of the chick primary hepatocyte cultures, 
the chicken hepatocellular carcinoma model (CLR-2118) previously described does 
have several advantages (Field et al. 2015).  Since it is an immortalized cell line 
propagation is relatively easy and there is little inter passage variation.  This lends 
confidence when comparing different experiments as genetic and metabolic change 
is minimal.   However, CLR-2118 cells still lack sufficient sensitivity since the 
CT50 is close to estimates of tissue DHPA concentrations and, for less toxic or 
difficult to isolate DHPAs it may not be possible to obtain enough alkaloid to 
thoroughly compare.  Further development of the chick primary hepatocyte cultures 
described herein may be warranted to further characterize the biphasic response and 
determine if the putative population of sensitive cells exists and can be isolated and 
cultured. 
 
Conclusions: These findings suggest chick primary hepatocytes cultures are highly 
sensitive to riddelliine cytotoxicity.  Primary chick hepatocyte cytotoxicity does not 
appear to be related to microsomal CYP3A4 activity.  However, some chick 
hepatocytes appeared to be resistant to riddelliine toxicity, or there occurs an 
inhibiting effect on riddelliine bioactivation, resulting in a biphasic response with 
sensitive cells damaged between 0.1 and 20 µM and more resistant cells requiring 
doses similar to rat and mouse hepatocytes.  More work is needed to better 
characterize these differences.  These findings also suggest that with improved 
isolation some highly sensitive primary chick hepatocytes may be useful in the 
direct comparison of a wide range of DHPAs, including those that are less toxic or 
difficult to isolate in larger quantities, as a preliminary screening of the cytotoxic 
potential at physiologically relevant concentrations.   
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